ArticleNature communications2025
Covid-19 and cardiovascular disease in a total population-study of long-term effects, social factors and Covid-19-vaccination.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Burden of cardiovascular disease in Brazil, 1996-2023: a retrospective descriptive study of the epidemiology and impact on public healthcare.Lancet regional health. Americas · 2027Article
- Therapies for Heart Failure: Clinical Updates and Perspectives.Journal of clinical medicine · 2026Article
- Viral Illness and Cardiovascular Disease.JACC. Advances · 2026Article
- Sex differences in immune responses to viruses, bacteria and vaccines.Nature immunology · 2026Review
- Review
- Impact of in-hospital SARS-CoV-2 infection on mortality and outcomes in patients admitted for heart failure: a nationwide analysis in Brazil.Frontiers in cardiovascular medicine · 2026Article
- Editorial: Metabolic dysregulation as a response to viral infections - a new culprit of metabolic diseases.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Understanding more about the risk of cardiovascular disease in the large population-group with mild Covid-19 is essential since the preventive need might be extensive. This study examined the risk of cardiovascular disease following Covid-19, considering risk periods and prognostic factors i.e., social factors, Covid-19-vaccination and comorbidities. The study cohort included the Swedish population aged 40-75 years (n = 4,095,414). Covid-19 was associated with elevated hazard ratios for all outcomes; ranging from 1.22 (95% confidence interval:1.14-1.31) for acute myocardial infarction to 4.31 (95% confidence interval:4.09-4.55) for pulmonary embolism. The increased risk was most evident among hospitalised individuals, however, also individuals with mild Covid-19 had an elevated risk. Finally, our findings demonstrated increased long-term cardiovascular risk and generally stronger effects of Covid-19 in more vulnerable social groups. In this work, we demonstrate an increased risk of cardiovascular disease after Covid-19, also among mild cases, findings relevant from both a public health and healthcare perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.